You can buy or sell HZNP and other stocks, options, ETFs, and crypto commission-free!
Horizon Therapeutics Public Limited Company Ordinary Shares, also called Horizon Therapeutics, is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. Read More The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. The listed name for HZNP is Horizon Therapeutics Public Limited Company Ordinary Shares.
52 Week High
52 Week Low
— per share
Expected Nov 4, Pre-Market